Xvivo Perfusion AB's market cap is currently $5.77B. The company's EPS TTM is kr0.05; its P/E ratio is 51.81; Xvivo Perfusion AB is scheduled to report earnings on July 11, 2025, and the estimated EPS forecast is kr0.58. See an overview of income statement, balance sheet, and cash flow financials.
